“And so the long-term model for us is to enable labs globally everywhere around the world to run this kind of testing in a way that is simple to adopt, much lower cost, much more reliable, um and can be run and locally near the patient so that those laboratories can retain some of the value um of running this kind of testing. So that's that's where we're ultimately heading.”